Mystery Child Hepatitis in 2022: What WHO Reported and the Cause

Facebook ↗WhatsApp ↗

First published April 27, 2022.

WHO's April 2022 Investigation Into Childhood Hepatitis

In April 2022 the World Health Organization warned of an unusual cluster of severe hepatitis, or liver inflammation, in young children. Its bulletin of 23 April counted at least 169 cases in 12 countries, in children aged one month to 16 years, none of whom had the usual hepatitis viruses A to E. Seventeen children needed liver transplants and at least one had died. Early reports often rounded the figure to 170 cases in 11 countries; the WHO's own count was 11 countries in Europe plus the United States.

Investigators first suspected a common virus, adenovirus. Studies published in 2023 pointed to a more complex picture involving a second virus, AAV2, and a genetic risk factor. Here is what was known at the time, what researchers later found, and what parents should take from it.

How the outbreak was spotted

Doctors in Scotland raised the alarm. On 31 March 2022, Public Health Scotland was told of five children aged three to five being treated at the Royal Hospital for Children in Glasgow for severe hepatitis with no obvious cause. That is a striking number for a condition that is normally rare in young children. Within days the UK reported more cases to the WHO, and the count kept rising: 74 by 8 April and 114 by 21 April.

Other countries then searched their records. By the time of the WHO bulletin, cases had been reported by Spain (13), Israel (12), the United States (9), Denmark (6), the Netherlands and Italy (4 each), Norway and France (2 each), Romania and Belgium (1 each) and Ireland (fewer than five). In the US, a cluster of nine previously healthy children had already been seen at a hospital in Alabama between October 2021 and February 2022. Investigators found no links between the children through travel, food, pets or contact with each other.

By July 2022, 35 countries had reported more than 1,000 probable cases.

Hepatitis explained

"Hepatitis" simply means inflammation of the liver. It can be caused by viruses, alcohol, some medicines, toxins and autoimmune disease. Five viruses are named after it:

  • Hepatitis A and E usually spread through contaminated food or water and most people recover fully.
  • Hepatitis B, C and D spread mainly through blood and other body fluids and can cause long-term liver damage, sometimes silently for decades.

The 2022 cases were puzzling precisely because none of these five viruses was found. Many children first had stomach symptoms such as diarrhoea, vomiting and abdominal pain, followed by jaundice (yellowing of the skin and eyes) and very high liver enzyme levels. Most did not have a fever.

The early theories

Adenovirus quickly became the leading suspect. These viruses are very common and usually cause colds, sore throats or tummy bugs. In the WHO's April data, adenovirus was detected in at least 74 cases, and by May about three-quarters of cases tested positive, often for type 41, which was known for gut infections but not for hepatitis in healthy children. Aikaterini Mougkou of the European Centre for Disease Prevention and Control summed up the uncertainty: "As we do not know the cause, we do not know the transmission route and how to prevent and treat it."

Scientists also asked why this was happening in 2022. One idea was that lockdowns had reduced children's exposure to common viruses, so many met adenovirus later and reacted more strongly. Another was that a previous Covid-19 infection might combine with adenovirus to trigger an abnormal immune response in the liver. SARS-CoV-2 was found in 20 of the early cases.

A common myth: Covid vaccines

Rumours online linked the cases to Covid-19 vaccines. The WHO noted that the vast majority of affected children had not been vaccinated, mainly because most were too young to be eligible, and said that vaccine side effects were not a supported hypothesis. Later research did not change that conclusion.

What researchers found in 2023

In March 2023, papers published in the journal Nature offered the strongest explanation so far. A study led by the MRC-University of Glasgow Centre for Virus Research examined 32 children with unexplained hepatitis and 74 control children. It found adeno-associated virus 2 (AAV2) in the livers of every child with acute hepatitis who was tested, and in the blood of 81% of patients compared with 7% of controls.

AAV2 is normally considered harmless and cannot multiply on its own; it needs a "helper" virus, usually an adenovirus. The researchers therefore think the illness most likely resulted from co-infection, with adenovirus possibly the underlying driver that is harder to detect. They also found that many affected children carried a gene variant called HLA-DRB1*04:01, which was uncommon in the control groups and may make some children more susceptible. Senior author Professor Emma Thomson said the presence of AAV2 "is associated with unexplained hepatitis in children", while stressing that more research is needed.

A surge of these common viruses after Covid restrictions eased fits with the timing of the outbreak, which helps explain why so many cases appeared at once.

What parents should watch for

Severe hepatitis in children remains rare, and most children who catch adenovirus recover without problems. Health agencies advised parents to be aware of the signs of hepatitis, especially jaundice, dark urine, pale stools, itchy skin and unusual tiredness, particularly if they follow a stomach bug. If you notice any of these in your child, talk to a doctor promptly. Ordinary hygiene, such as regular handwashing and covering coughs and sneezes, reduces the spread of the viruses involved.

Sources: WHO Disease Outbreak News, 23 April 2022: Acute hepatitis of unknown aetiology in children; Wikipedia: 2022 hepatitis of unknown origin in children; University of Glasgow, 30 March 2023: Strong evidence that AAV2 played a key role in child hepatitis cases. Aikaterini Mougkou quote as reported by the South China Morning Post.

COMMENTS